Plasma membrane calcium ATPase overexpression in arterial smooth muscle increases vasomotor responsiveness and blood pressure

Circulation Research

Volumn 93, Issue 7, 2003, Pages 614-621

  Gros, Robert ^b   Afroze, Talat ^b   You, Xiao Mang ^b   Kabir, Golam ^b   Van Wert, Ryan ^b   Kalair, Waseem ^b   Hoque, Abunasr E ^b   Mungrue, Imran N ^b   Husain, Mansoor ^a  

^a TORONTO GENERAL HOSPITAL   (Canada)

^b NONE

Author keywords

Blood pressure; Intracellular calcium; Myogenic tone; Nitric oxide synthase; Transgenic mice

Indexed keywords

ADENOSINE TRIPHOSPHATASE (CALCIUM); CALCIUM ION; CYCLIC GMP; DOXYCYCLINE; PHENYLEPHRINE; VASOCONSTRICTOR AGENT; ARGININE; ATP2B1 PROTEIN, HUMAN; ATP2B1 PROTEIN, MOUSE; CALCIUM; CATION TRANSPORT PROTEIN; DRUG DERIVATIVE; ENZYME INHIBITOR; ISOENZYME; N(G) NITROARGININE METHYL ESTER; N(OMEGA) PROPYLARGININE; N(OMEGA)-PROPYLARGININE; NEURONAL NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE; NOS1 PROTEIN, HUMAN; NOS1 PROTEIN, MOUSE; PLASMA MEMBRANE CALCIUM TRANSPORTING ADENOSINE TRIPHOSPHATASE; POTASSIUM CHLORIDE;

ANIMAL CELL; ARTERY MUSCLE; ARTICLE; BLOOD PRESSURE REGULATION; BLOOD VESSEL TONE; CALCIUM CELL LEVEL; CELL MEMBRANE TRANSPORT; CONTROLLED STUDY; GENE EXPRESSION; GENE OVEREXPRESSION; HEART MUSCLE; MOUSE; MUSCLE TONE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSGENIC MOUSE; VASOMOTOR REFLEX; ADRENERGIC SYSTEM; ANIMAL; AORTA; BLOOD PRESSURE; CELL CULTURE; CELL LINE; CYTOLOGY; DOSE RESPONSE; DRUG ANTAGONISM; DRUG EFFECT; ENZYMOLOGY; FEMALE; GENE EXPRESSION REGULATION; GENETICS; GENOTYPE; HUMAN; IN VITRO STUDY; MALE; MESENTERIC ARTERY; METABOLISM; PHYSIOLOGY; VASCULAR SMOOTH MUSCLE; VASOCONSTRICTION;

ANIMALS; AORTA; ARGININE; BLOOD PRESSURE; CALCIUM; CALCIUM-TRANSPORTING ATPASES; CATION TRANSPORT PROTEINS; CELL LINE; CELLS, CULTURED; CYCLIC GMP; DOSE-RESPONSE RELATIONSHIP, DRUG; DOXYCYCLINE; ENZYME INHIBITORS; FEMALE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENOTYPE; HUMANS; ISOENZYMES; MALE; MESENTERIC ARTERIES; MICE; MICE, TRANSGENIC; MUSCLE, SMOOTH, VASCULAR; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE I; PHENYLEPHRINE; PLASMA MEMBRANE CALCIUM-TRANSPORTING ATPASES; POTASSIUM CHLORIDE; VASOCONSTRICTION; VASOMOTOR SYSTEM;

EID: 0141819124     PISSN: 00097330     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.RES.0000092142.19896.D9     Document Type: Article

References (41)

1. Garbers DL, Dubois SK. The molecular basis of hypertension. Annu Rev Biochem. 1999;68:127-155.
2. Faraci FM, Sigmund CD. Vascular biology in genetically altered mice: smaller vessels, bigger insight. Circ Res. 1999;85:1214-1225.
3. Folkow B. Physiological aspects of primary hypertension. Physiol Rev. 1982;62:347-504.
4. Carafoli E. Calcium pump of the plasma membrane. Physiol Rev. 1991;71:129-153.
5. Strehler EE, Zacharias DA. Role of alternative splicing in generating isoform diversity among plasma membrane calcium pumps. Physiol Rev. 2001;81:21-50.
6. 2+-ATPase. Am J Physiol. 1997;272:C1947-C1959.
7. 2+ ATPase-4 in the vascular smooth muscle cell cycle. Am J Physiol Cell Physiol. 2003;285:C88-C95.
8. Monteith GR, Kable EP, Chen S, Roufogalis BD. Plasma membrane calcium pump-mediated calcium efflux and bulk cytosolic free calcium in cultured aortic smooth muscle cells from spontaneously hypertensive and Wistar-Kyoto normotensives rats. J Hypertens. 1996;14:435-442.
9. 2+ pump mRNA levels in cultured aortic smooth muscle cells from spontaneously hypertensive rats. Biochem Biophys Res Commun. 1997;230:344-346.
10. 2+ pump isoform 1a. J Biol Chem. 1996;271:5536-5544.
11. Hammes A, Oberdorf-Maass S, Rother T, Nething K, Gollnick F, Linz KW, Meyer R, Hu K, Han H, Gaudron P, Ertl G, Hoffmann S, Ganten U, Vetter R, Schuh K, Benkwitz C, Zimmer HG, Neyses L. Overexpression of the sarcolemmal calcium pump in the myocardium of transgenic rats. Circ Res. 1998;83:877-888.
12. Fujimoto T. Calcium pump of the plasma membrane is localized in caveolae. J Cell Biol. 1993;120:1147-1157.
13. Chang WJ, Ying YS, Rothberg KG, Hooper NM, Turner AJ, Gambliel HA, De Gunzburg J, Mumby SM, Gilman AG, Anderson RG. Purification and characterization of smooth muscle cell caveolae. J Cell Biol. 1994;126:127-138.
14. Segal SS, Brett SE, Sessa WC. Codistribution of NOS and caveolin throughout peripheral vasculature and skeletal muscle of hamsters. Am J Physiol. 1999;277:H1167-H1177.
15. Schuh K, Uldrijan S, Telkamp M, Rothlein N, Neyses L. The plasma membrane calmodulin-dependent calcium pump: a major regulator of nitric oxide synthase I. J Cell Biol. 2001;155:201-205.
16. Ju H, Gros R, You X, Tsang S, Husain M, Rabinovitch M. Conditional and targeted overexpression of vascular chymase causes hypertension in transgenic mice. Proc Natl Acad Sci U S A. 2001;98:7469-7474.
17. You X-M, Mungrue IN, Kalair W, Afroze T, Ravi B, Sadi AM, Gros R, Husain M. Conditional expression of a dominant-negative c-Myb in vascular smooth muscle cells inhibits arterial remodeling after injury. Circ Res. 2003;92:314-321.
18. 2+ pump and of its N-terminally truncated 105-kDa fragment. J Biol Chem. 1992;267:24476-24484.
19. Mungrue IN, Gros R, You X, Pirani A, Azad A, Csont T, Schulz R, Butany J, Stewart DJ, Husain M. Cardiomyocyte overexpression of iNOS in mice results in peroxynitrite generation, heart block, and sudden death. J Clin Invest. 2002;109:735-743.
20. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 1987;162:156-159.
21. Caride AJ, Filoteo AG, Enyedi A, Verma AK, Penniston JT. Detection of isoform 4 of the plasma membrane calcium pump in human tissues by using isoform-specific monoclonal antibodies. Biochem J. 1996;316:353-359.
22. de Talamoni N, Smith CA, Wasserman RH, Beltramino C, Fullmer CS, Penniston JT. Immunocytochemical localization of the plasma membrane calcium pump, calbindin-D28k, and parvalbumin in Purkinje cells of avian and mammalian cerebellum. Proc Natl Acad Sci USA. 1993;90:11949-11953.
23. 2+-)-ATPase of the erythrocyte membrane: reconstitution and effect of calmodulin and phospholipids. J Biol Chem. 1981;256:395-401.
24. 2+ storage in cultured vascular smooth muscle cells. Circ Res. 1997;80:617-626.
25. Shakil T, Hoque AN, Husain M, Belsham DD. Differential regulation of gonadotropin-releasing hormone secretion and gene expression by androgen: membrane versus nuclear receptor activation. Mol Endocrinol. 2002;16:2592-2602.
26. 2+ indicators with greatly improved fluorescence properties. J Biol Chem. 1985; ; 260:3440-3450.
27. Gros R, Van Wert R, You X, Thorin E, Husain M. Effects of age, gender, and blood pressure on myogenic responses of mesenteric arteries from C57BL/6 mice. Am J Physiol Heart Circ Physiol. 2002;282:H380-H388.
28. Pearce LL, Gandley RE, Han W, Wasserloos K, Stitt M, Kanai AJ, McLaughlin MK, Pitt BR, Levitan ES. Role of metallothionein in nitric oxide signaling as revealed by a green fluorescent fusion protein. Proc Natl Acad Sci USA. 2000;97:477-482.
29. Scotland RS, Chauhan S, Vallance PJ, Ahluwalia A. An endothelium-derived hyperpolarizing factor-like factor moderates myogenic constriction of mesenteric resistance arteries in the absence of endothelial nitric oxide synthase-derived nitric oxide. Hypertension. 2001;38:833-839.
30. ω -propyl-L-arginine. J Med Chem. 1997;40:3869-3870.
31. Boulanger CM, Heymes C, Benessiano J, Geske RS, Levy BI, Vanhoutte PM. Neuronal nitric oxide synthase is expressed in rat vascular smooth muscle cells: activation by angiotensin II in hypertension. Circ Res. 1998;83:1271-1278.
32. Staunton M, Drexler C, Schmid PG 3rd, Havlik HS, Hudetz AG, Farber NE. Neuronal nitric oxide synthase mediates halothane-induced cerebral microvascular dilation. Anesthesiology. 2000;92:125-132.
33. Xu L, Carter EP, Ohara M, Martin PY, Rogachev B, Morris K, Cadnapaphornchai M, Knotek M, Schrier RW. Neuronal nitric oxide synthase and systemic vasodilation in rats with cirrhosis. Am J Physiol Renal Physiol. 2000;279:F1110-F1115.
34. Mason CA, Chang P, Fallery C, Rabinovitch M. Nitric oxide mediates LC-3-dependent regulation of fibronectin in ductus arteriosus intimal cushion formation. FASEB J. 1999;13:1423-1434.
35. Adams ME, Mueller HA, Froehner SC. In vivo requirement of the α-syntrophin PDZ domain for the sarcolemmal localization of nNOS and aquaporin-4. J Cell Biol. 2001;155:113-122.
36. Sunada Y, Ohi H, Hase A, Hosono T, Arata S, Higuchi S, Matsumura K, Shimizu T. Transgenic mice expressing mutant caveolin-3 show severe myopathy associated with increased nNOS activity. Hum Mol Genet. 2001;10:173-178.
37. Huang Z, Huang PL, Panahian N, Dalkara T, Fishman MC, Moskowitz MA. Effects of cerebral ischemia in mice deficient in neuronal nitric oxide synthase. Science. 1994;265:1883-1885.
38. Jumrussirikul P, Dinerman J, Dawson TM, Dawson VL, Ekelund U, Georgakopoulos D, Schramm LP, Calkins H, Snyder SH, Hare JM, Berger RD. Interaction between neuronal nitric oxide synthase and inhibitory G protein activity in heart rate regulation in conscious mice. J Clin Invest. 1998;102:1279-1285.
39. Huang PL, Dawson TM, Bredt DS, Snyder SH, Fishman MC. Targeted disruption of the neuronal nitric oxide synthase gene. Cell. 1993;75:1273-1286.
40. Gyurko R, Leupen S, Huang PL. Deletion of exon 6 of the neuronal nitric oxide synthase gene in mice results in hypogonadism and infertility. Endocrinology. 2002;143:2767-2774.
41. Karaki H, Ozaki H, Hori M, Mitsui-Saito M, Amano K, Harada K, Miyamoto S, Nakazawa H, Won KJ, Sato K. Calcium movements, distribution, and functions in smooth muscle. Pharmacol Rev. 1997;49:157-230.